Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_assertion type Assertion NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_head.
- NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_assertion wasGeneratedBy ECO_0000203 NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_provenance.
- NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_assertion wasDerivedFrom befree-20150227 NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_provenance.
- NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_assertion SIO_000772 6893937 NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_provenance.
- NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_assertion evidence source_evidence_literature NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_provenance.
- NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_assertion description "[Riboflavin is considered to be effective by activating the NADPH diaphorase (NADPH flavin reductase) system and appears to be useful for the treatment of congenital methaemoglobinaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354705.RA-mO-bOIs5v0-LK9OM4ETsvbK-MVNTAOVRn9MxDYQI_c130_provenance.